NIMA-related kinase 2 (NEK2), a member of the NIMA-related kinase family, activates the NF-κB signaling pathway by phosphorylating NIK and increasing its activity and stability, promoting the malignant progression of GBM [57]. This evidence concerns the gene NFKB1 and glioblastoma.